GSK to acquire Stiefel

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) will acquire dermatology company Stiefel Laboratories Inc. (Coral Gables, Fla.) for $2.9 billion

Read the full 177 word article

How to gain access

Continue reading with a
two-week free trial.